Microdosing Ozempic? Why some people are playing doctor with weight-loss drugs
Feb. 22, 2024 When the semaglutide medication Wegovy first hit the market in 2021, it became the first weight-loss drug to get FDA approval since 2014 and immediately became the go-to weight-loss treatment. At the heart of these medications are two key ...
Amid backlash, FDA changes course over shortage of weight-loss drugs
The FDA said Eli Lilly’s weight-loss drugs were no longer in shortage on Oct. 2, preventing pharmacies from making cheaper versions. After an outcry, it’s reconsidering.
Are Diabetes Drugs Really Safe (& Reliable) for Weight Loss?
There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight loss. Whether you have type 2 diabetes or obesity, you may have heard about medications like Ozempic® that can help manage blood sugar levels and weight.
The end of a shortage of popular weight-loss drugs may mean many people lose access to them
Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a shortage of the brand-name drug has ended – which means compounding of the medicine must stop.
A new weight loss drug could beat Ozempic's side effect problem
The Denmark-based drug maker Zealand Pharma said Tuesday that its experimental weight-loss drug could help patients lose pounds with fewer side effects than current anti-obesity medications on the market.
Concern over counterfeit versions of weight loss drugs like Ozempic
Experts say as drugs like Ozempic and Wegovy grow in popularity, it presents the chance for fake versions to make their way onto the market.
You Can Now Get Prescription Weight Loss Drugs Like Ozempic From An Online Telehealth Visit. But Is It Safe?
These drugs have also been in and out of shortage, making it tough to get your hands on Ozempic and similar medications—if you can afford it. Semaglutide medications like Ozempic and Wegovy are also reportedly getting closer to moving off the shortages list,
FDA Warns About Popular Weight-Loss Drugs Distributed By SoCal Company
The FDA urges healthcare professionals to stop administering the products, and patients should stop using them.
FDA says this weight loss drug shortage is over, but patients worry about cost and availability
Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.
FDA's Weight Loss Drug 'No Man's Land' Adds Risk for Compounders
Pharmacies currently making copycat versions of Eli Lilly’s tirzepatide face heightened exposure to state enforcement actions ...
STAT2d
Pharmalittle: We’re reading about a weight loss pill, the FDA warning a compounder, and more
European Union antitrust regulators will decide by Dec. 6 whether to clear Novo Holdings’ acquisition of contract drug ...
Women turn to weight loss drugs in menopause: What to know about the benefits and risks
Both Ozempic and Mounjaro are approved by the U.S. Food and Drug Administration to treat Type 2 diabetes, but some ...
AOL24d
FDA shakes up weight loss market as Mounjaro shortage ends
Federal regulators shook up the booming weight loss drug marketplace ... Tirzepatide was first approved by the Food and Drug Administration (FDA) in 2022 and has no generic versions on the ...
7 common myths about semaglutide and weight loss debunked
Wegovy® is the only version of semaglutide that is FDA-approved for weight loss, while Ozempic® and other forms of the drug ...